For more information or confidential assistance
800-306-3180
se habla español

Federal Farxiga Lawsuits Consolidated in NY

The makers of Farxiga, Bristol-Myers Squibb and AstraZeneca, are facing at least 18 product liability lawsuits filed in federal courts. These have now been centralized into a multidistrict litigation (MDL) pursuant to an order issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued on April 6, 2017. The... Read more »

FDA Invokana Study Finds Potential Amputation Link

The U.S. Food and Drug Administration has issued a new safety alert regarding the type 2 diabetes drug canagliflozin — Invokana and Invokamet. The Agency issued a safety announcement on May 18, notifying patients and the medical community that results of an ongoing clinical trial revealed a higher number of... Read more »

Study Suggests Risperdal Boosts Childhood Diabetes Risk

A report recently published in the renowned JAMA Psychiatry journal indicates that children who are given antipsychotic drugs including Risperdal, Seroquel and Zyprexa may experience a greater likelihood of developing diabetes than those who have not been prescribed those medications to treat their mental health conditions. The study, conducted by doctors from... Read more »

Report Highlights Risks of Newer Diabetes Drugs

Metabolic acidosis is a risk associated with Invokana that was recently highlighted in a report by the Institute for Safe Medical Practices (ISMP). Invokana is one of the drugs recently touted for its ability to manage type 2 diabetes, but potential side effects have raised concerns and led to a... Read more »

Diabetic Ketoacidosis Prompts Invokana Lawsuit

A California woman has filed a product lability lawsuit against Janssen Pharmaceuticals and Johnson & Johnson, alleging that the defendants’ product, Invokana, caused serious complications. Jennifer Anzo filed the Invokana lawsuit late in October 2015 in the U.S. District Court for the Eastern District of California. She is demanding compensation... Read more »

Plaintiff Blames Invokana for Severe Kidney Damage

Plaintiff Gene Schurman, a resident of Illinois, claims he suffered severe kidney damage after taking the diabetes drug Invokana under the direction of his doctor. He is now suing Janssen Pharmaceuticals, Johnson & Johnson and Mitsubishi Tanabe Pharma Corporation on claims of failure to warn, product liability, design defect, fraud,... Read more »

FDA Declines Approval of New Combination Diabetes Drug

London-based AstraZeneca failed to obtain FDA approval for a proposed diabetes drug that combines two different medications, saxagliptin and dapagliflozin. In October 2015, the FDA issued a complete response letter to the pharmaceutical giant’s application. The agency requested additional clinical research on the proposed combination drug. AstraZeneca recently released statements... Read more »